Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Key Highlights Capital Improvement Framework: At the core the plan is a Capital Improvement Framework
The SLC25 Carrier Family: Important Transport Proteins in Mitochondrial Physiology and Pathology
Max International launched in the United States in 2007
Tirzepatide for the treatment of adults with type 2 diabetes: an endocrine perspective
The increasing biosimilars approvals and expanding global biosimilars market size will propel the demand for protein A resins from biosimilar companies
US$ 20.78
US$ 22.02
US$ 27.45
US$ 22.82
/assets/images/provider/photos/2786748.jpg)
US$ 28.47
US$ 28.39
US$ 24.85
US$ 24.14
US$ 23.86
